Neprilysin and Hypertension: Cause, Consequence, or Marker?
The Journal of Clinical Hypertension · 2026-05 · 28 (5)
DOI: 10.1111/jch.70294 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Journal of Clinical Hypertension, online erschienen am 16.05.2026. Verfasst von Muhammad Qaseem und 1 weiteren Autor:innen. Beteiligte Einrichtung: Khyber Medical College, Peshawar, Khyber Pakhtunkhwa, Pakistan. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Khyber Medical College, Peshawar, Khyber Pakhtunkhwa, Pakistan.
ORCID-Profile: Muhammad Qaseem, Shehbaz Ali
Zitieren
APA
Qaseem, M., & Ali, S. (2026). Neprilysin and Hypertension: Cause, Consequence, or Marker?. The Journal of Clinical Hypertension, 28(5). https://doi.org/10.1111/jch.70294
Vancouver
Qaseem M, Ali S. Neprilysin and Hypertension: Cause, Consequence, or Marker?. The Journal of Clinical Hypertension. 2026;28(5). doi:10.1111/jch.70294
BibTeX
@article{Qaseem2026,
author = {Qaseem, Muhammad and Ali, Shehbaz},
title = {Neprilysin and Hypertension: Cause, Consequence, or Marker?},
journal = {The Journal of Clinical Hypertension},
year = {2026},
volume = {28},
number = {5},
doi = {10.1111/jch.70294}
}
EUVIMED